Valuation: Masimo Corporation

Market Cap 9.42B 8.14B 7.65B 6.96B 13.08B 901B 13.29B 89.61B 35.04B 451B 35.38B 34.61B 1,499B P/E 2024
-29.9x
P/E 2025 -45.5x
Enterprise Value 9.83B 8.49B 7.98B 7.26B 13.64B 940B 13.87B 93.48B 36.55B 471B 36.91B 36.11B 1,564B EV / Sales 2024
4.7x
EV / Sales 2025 4.75x
Free-Float
66.12%
Yield 2024 *
-
Yield 2025 -
1 day+0.01%
3 months+0.90%
6 months+38.26%
Current year+38.36%
Current year 125.94
Extreme 125.94
179.99
1 year 125.94
Extreme 125.94
179.99
3 years 75.22
Extreme 75.22
194.88
5 years 75.22
Extreme 75.22
305.21
10 years 53.78
Extreme 53.78
305.21
Manager TitleAgeSince
President - 02/08/2026
Chief Tech/Sci/R&D Officer - -
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member - 09/06/2026
Date Insider Type Main position Quantity % Market Cap.
10/06/26 Issuer sale

Responsable ventes & marketing

-13,318 0.0254%
23/04/26 Fiscal year

Chairman

3,569 0.0068%
06/03/26 Free

Head of Human Resources

5,985 0.0115%
Change 5-day change 1-year change 3-year change Capi.($)
+0.01%-.--%+18.49%+59.47% 9.42B
+0.08%+0.73%+29.15%+27.93% 12.88B
+0.08%+1.31%+18.98%+27.31% 6.88B
-0.97%+5.01%+55.52%+37.30% 6.46B
+0.65%+2.81% - - 5.66B
+0.14%+4.47%-25.15%+48.54% 4.56B
-1.67%-3.33%-25.90%-23.12% 3.91B
-2.47%+3.42%+46.25%-45.25% 1.97B
-1.94%+1.08%+60.00%-6.29% 1.71B
-2.80%-11.09%-29.59%+112.65% 1.55B
Average -0.89%+1.98%+16.42%+26.50% 5.5B
Weighted average by Cap. -0.35%+1.83%+19.68%+31.50%

Financials

2024 2025
Net sales 2.09B 1.81B 1.7B 1.55B 2.91B 200B 2.95B 19.92B 7.79B 100B 7.86B 7.69B 333B 1.53B 1.32B 1.24B 1.13B 2.12B 146B 2.15B 14.52B 5.68B 73.11B 5.73B 5.61B 243B
Net income -305M -263M -247M -225M -423M -29.16B -430M -2.9B -1.13B -14.6B -1.14B -1.12B -48.52B -152M -131M -123M -112M -210M -14.49B -214M -1.44B -563M -7.25B -569M -556M -24.11B
Net Debt 668M 577M 543M 493M 928M 63.92B 943M 6.36B 2.49B 32.01B 2.51B 2.46B 106B 407M 352M 330M 300M 565M 38.92B 574M 3.87B 1.51B 19.49B 1.53B 1.49B 64.76B
Logo Masimo Corporation
Masimo Corporation is a global medical technology company that develops and produces a wide range of monitoring technologies, including measurements, sensors, patient monitors, automation and connectivity solutions. The Company’s healthcare products and patient monitoring solutions generally incorporate a monitor or circuit board, proprietary single-patient use or reusable sensors, software and/or cables. It primarily sells its healthcare products to hospitals, emergency medical service providers, home care providers, physician offices, veterinarians, long-term care facilities. Its measurement technologies include Measure-through Motion and Low Perfusion pulse oximetry, known as Masimo Signal Extraction Technology (SET) pulse oximetry, and advanced rainbow Pulse CO-Oximetry parameters such as noninvasive hemoglobin (SpHb), alongside many other modalities, including brain function monitoring, hemodynamic monitoring, regional oximetry, capnography and gas monitoring, and others.
Employees
2,200
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BB
  1. Stock Market
  2. Stocks
  3. MASI Stock